Podocytopathies

JB Kopp, HJ Anders, K Susztak, MA Podestà… - Nature Reviews …, 2020 - nature.com
Podocytopathies are kidney diseases in which direct or indirect podocyte injury drives
proteinuria or nephrotic syndrome. In children and young adults, genetic variants in> 50 …

Autophagy in kidney homeostasis and disease

C Tang, MJ Livingston, Z Liu, Z Dong - Nature Reviews Nephrology, 2020 - nature.com
Autophagy is a conserved lysosomal pathway for the degradation of cytoplasmic
components. Basal autophagy in kidney cells is essential for the maintenance of kidney …

[HTML][HTML] Sparsentan versus irbesartan in focal segmental glomerulosclerosis

MN Rheault, CE Alpers, J Barratt, S Bieler… - … England Journal of …, 2023 - Mass Medical Soc
Background An unmet need exists for focal segmental glomerulosclerosis (FSGS) treatment.
In an 8-week, phase 2 trial, sparsentan, a dual endothelin–angiotensin receptor antagonist …

Insights into new-onset autoimmune diseases after COVID-19 vaccination

M Guo, X Liu, X Chen, Q Li - Autoimmunity reviews, 2023 - Elsevier
Abstract Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2), has resulted in more than 670 million infections and …

Cellular and molecular mechanisms of kidney fibrosis

S Djudjaj, P Boor - Molecular aspects of medicine, 2019 - Elsevier
Renal fibrosis is the final pathological process common to any ongoing, chronic kidney
injury or maladaptive repair. It is considered as the underlying pathological process of …

Precision nephrology identified tumor necrosis factor activation variability in minimal change disease and focal segmental glomerulosclerosis

LH Mariani, S Eddy, FM AlAkwaa, PJ McCown… - Kidney international, 2023 - Elsevier
The diagnosis of nephrotic syndrome relies on clinical presentation and descriptive patterns
of injury on kidney biopsies, but not specific to underlying pathobiology. Consequently, there …

Safety and efficacy of dapagliflozin in patients with focal segmental glomerulosclerosis: a prespecified analysis of the dapagliflozin and prevention of adverse …

DC Wheeler, N Jongs, BV Stefansson… - Nephrology Dialysis …, 2022 - academic.oup.com
Background Despite renin–angiotensin–aldosterone system blockade and
immunosuppressive treatment, focal segmental glomerulosclerosis (FSGS) often progresses …

[HTML][HTML] Management and treatment of glomerular diseases (part 2): conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies …

BH Rovin, DJ Caster, DC Cattran, KL Gibson… - Kidney international, 2019 - Elsevier
In November 2017, the Kidney Disease: Improving Global Outcomes (KDIGO) initiative
brought a diverse panel of experts in glomerular diseases together to discuss the 2012 …

Single-cell transcriptome profiling of the kidney glomerulus identifies key cell types and reactions to injury

JJ Chung, L Goldstein, YJJ Chen, J Lee… - Journal of the …, 2020 - journals.lww.com
Background The glomerulus is a specialized capillary bed that is involved in urine
production and BP control. Glomerular injury is a major cause of CKD, which is epidemic …

Focal segmental glomerulosclerosis: state-of-the-art and clinical perspective

A Shabaka, A Tato Ribera, G Fernández-Juárez - Nephron, 2020 - karger.com
Focal segmental glomerulosclerosis (FSGS) is a histological pattern of glomerular injury,
rather than a single disease, that is caused by diverse clinicopathological entities with …